Skip to main content

Roche Pharma Day 2026

Monday, 28th September 2026, 09:00am BST/10:00am CEST, London

Please register to access the live event here*

Agenda
Agenda
WelcomeBruno Eschli, Head of Investor Relations
Pharma Strategy and Commercial Growth DriversTeresa Graham, CEO Roche Pharmaceuticals
R&D ExcellenceLevi Garraway, CMO and Head Global Product Development and Chief Medical Officer
Revolutionizing drug R&D with Lab in a LoopAviv Regev, Head of Genentech Research and Early Development (gRED)
Financial Excellence and DigitalizationAlan Hippe, CFO Roche Group
Oncology/HematologyLevi Garraway and Matt Hellmann, SVP and Global Head of Oncology Product Development
NeurologyHideki Garren, SVP and Global Head of Neurology Product Development
ImmunologyLarry Tsai, SVP and Global Head of Immunology Product Development
OphthalmologyChristopher Brittain, SVP and Global Head of Ophthalmology Product Development
Cardiovascular, Renal and MetabolismManu Chakravarthy, SVP and Global Head of Cardiovascular, Renal and Metabolism Product Development
InvestorsPast IR Events
View more Events, Past IR Events

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments.

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.